Ignite Creation Date:
2024-05-06 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03020342
Status:
UNKNOWN
Last Update Posted:
2017-01-13
First Post:
2016-06-22
Brief Title:
HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC
Sponsor:
Organization:
National Taiwan University Hospital
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Tumor T and non-Tumor NT tissue and peripheral blood
Enrollment Count:
50
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Only |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 39066 |
Who Masked List: